Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Ageing as a risk factor for neurodegenerative disease

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Calcitonin gene-related peptide - beyond migraine prophylaxis

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  2. Does inflammation have a role in migraine?

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. CGRP as the target of new migraine therapies - successful translation from bench to clinic

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. The current role of MRI in differentiating multiple sclerosis from its imaging mimics

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. Human models of migraine - short-term pain for long-term gain

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Automatically computed rating scales from MRI for patients with cognitive disorders

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Ventriculoperitoneal Shunt Complications in the European Idiopathic Normal Pressure Hydrocephalus Multicenter Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Ageing is the primary risk factor for most neurodegenerative diseases, including Alzheimer disease (AD) and Parkinson disease (PD). One in ten individuals aged ≥65 years has AD and its prevalence continues to increase with increasing age. Few or no effective treatments are available for ageing-related neurodegenerative diseases, which tend to progress in an irreversible manner and are associated with large socioeconomic and personal costs. This Review discusses the pathogenesis of AD, PD and other neurodegenerative diseases, and describes their associations with the nine biological hallmarks of ageing: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, deregulated nutrient sensing, stem cell exhaustion and altered intercellular communication. The central biological mechanisms of ageing and their potential as targets of novel therapies for neurodegenerative diseases are also discussed, with potential therapies including NAD+ precursors, mitophagy inducers and inhibitors of cellular senescence.

OriginalsprogEngelsk
TidsskriftNature reviews. Neurology
Vol/bind15
Udgave nummer10
Sider (fra-til)565-581
Antal sider17
ISSN1759-4758
DOI
StatusUdgivet - okt. 2019

ID: 58035588